£88.21

Springer Noncolorectal, Nonneuroendocrine Liver Metastases: Diagnosis and Current Therapies

Price data last checked 26 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£88 today · previous high £88 · all-time low £88

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical
Generating forecast…
£88.21 £88.17 £88.18 £88.19 £88.19 £88.20 £88.21 07 June 2026 23 June 2026 09 July 2026 25 July 2026 10 August 2026

Price Distribution

Price distribution over 65 days • 1 price levels

Days at Price
65 days 0 16 33 49 65 £88 Days at Price

Price Analysis

Most common price: £88 (65 days, 100.0%)

Price range: £88 - £88

Price levels: 1 different prices over 65 days

Description

This book offers a complete overview on non colorectal non neuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history and diagnosis. NCRNNE liver metastases are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies. From the Back Cover This book offers a complete overview on noncolorectal nonneuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history, and diagnosis. NCRNNE metastases to the liver are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy, and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Liver Metastases
89% match

Liver Metastases

Springer

£80.67 08 Aug 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
82% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.67 05 Aug 2026
Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)
82% match

Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)

Springer

£71.94 08 Aug 2026
Management of Pancreatic Cancer and Cholangiocarcinoma
81% match

Management of Pancreatic Cancer and Cholangiocarcinoma

Springer

£103.27 18 Aug 2026
Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)
81% match

Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)

Springer

£113.76 05 Aug 2026
Triple-Negative Breast Cancer: A Clinician’s Guide
80% match

Triple-Negative Breast Cancer: A Clinician’s Guide

Springer

£80.67 03 Aug 2026
Non-Neoplastic Liver Pathology: A Pathologist’s Survival Guide
80% match

Non-Neoplastic Liver Pathology: A Pathologist’s Survival Guide

Springer

£92.00 08 Aug 2026
Central Nervous System Metastasis, the Biological Basis and Clinical Considerations: 18 (Cancer Metastasis - Biology and Treatment, 18)
80% match

Central Nervous System Metastasis, the Biological Basis and Clinical Considerations: 18 (Cancer Metastasis - Biology and Treatment, 18)

Springer

£113.76 06 Aug 2026
Colon Cancer Diagnosis and Therapy: Volume 2
80% match

Colon Cancer Diagnosis and Therapy: Volume 2

Springer

£121.64 08 Aug 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
80% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£108.01 06 Aug 2026
Uncommon Pancreatic Neoplasms (Updates in Surgery)
80% match

Uncommon Pancreatic Neoplasms (Updates in Surgery)

Springer

£88.21 08 Aug 2026
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
80% match

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

Springer

£78.01 04 Aug 2026
Medullary Thyroid Cancer
80% match

Medullary Thyroid Cancer

Springer

£88.17 30 Jun 2026
Non-coding RNAs and Cancer
80% match

Non-coding RNAs and Cancer

Springer

£80.67 06 Aug 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
79% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£66.33 05 Aug 2026
Molecular Targeted Therapy of Lung Cancer
79% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Imaging and Pathology of Pancreatic Neoplasms: A Pictorial Atlas
79% match

Imaging and Pathology of Pancreatic Neoplasms: A Pictorial Atlas

Springer

£89.99 10 Aug 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
79% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.65 05 Aug 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
79% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£113.76 03 Jul 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
79% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£114.71 07 Aug 2026
Hilar Cholangiocarcinoma
79% match

Hilar Cholangiocarcinoma

Springer

£81.74 06 Aug 2026
Critical Issues in Head and Neck Oncology: Key Concepts from the Seventh THNO Meeting
79% match

Critical Issues in Head and Neck Oncology: Key Concepts from the Seventh THNO Meeting

Springer

£40.68 08 Aug 2026
Nuclear Oncology
79% match

Nuclear Oncology

Springer

£114.89 08 Aug 2026
Lentigo Maligna Melanoma: Challenges in Diagnosis and Management
79% match

Lentigo Maligna Melanoma: Challenges in Diagnosis and Management

Springer

£98.42 04 Aug 2026